Inventor · disambiguated record
Sek Chung Fung
Also filed as: FUNG SEK C · FUNG SEK C M · FUNG SEK CHUNG · FUNG SEK CHUNG MICHAEL
27 granted patents·18 pending applications·529 citations·filing 1993–2019
97Inventor score
Top patents by PatentIndex Score
45 records- 0197US8753625B2Use of complement inhibitors to treat ocular diseasesFUNG SEK CHUNG·Filed 2006·Granted Jun 17, 2014·62 cites·38 claims
- 0296US8318160B2Treatment of cancer with novel anti-IL13 monoclonal antibodiesFUNG SEK CHUNG·Filed 2010·Granted Nov 27, 2012·29 cites·51 claims
- 0396US8088618B2Anti-IL 13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2008·Granted Jan 3, 2012·41 cites·37 claims
- 0496US7674459B2Treatment of cancer with a novel anti-IL13 monoclonal antibodyGENENTECH INC·Filed 2004·Granted Mar 9, 2010·56 cites·30 claims
- 0595US8372403B2Humanized anti-factor D antibodies and uses thereofGENENTECH INC·Filed 2012·Granted Feb 12, 2013·17 cites·31 claims
- 0695US8067002B2Humanized anti-factor D antibodiesAN LING-LING·Filed 2007·Granted Nov 29, 2011·29 cites·28 claims
- 0794US9605065B2Anti-IL13 antibodies and uses thereofGENENTECH INC·Filed 2013·Granted Mar 28, 2017·17 cites·24 claims
- 0894US7994285B2Anti-Notch3 antibodiesGENENTECH INC·Filed 2007·Granted Aug 9, 2011·19 cites·9 claims
- 0994US7935791B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesGENENTECH INC·Filed 2007·Granted May 3, 2011·25 cites·11 claims
- 1093US8193329B2Nucleic acids encoding anti-factor D antibodiesAN LING-LING·Filed 2011·Granted Jun 5, 2012·15 cites·44 claims
- 1193US8067199B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2004·Granted Nov 29, 2011·39 cites·50 claims
- 1292US8187604B2Methods of treating with anti-factor D antibodiesAN LING-LING·Filed 2011·Granted May 29, 2012·12 cites·39 claims
- 1392US7915390B2Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseasesGENENTECH INC·Filed 2007·Granted Mar 29, 2011·22 cites·19 claims
- 1491US8753826B2Methods of detecting factor D with anti-factor D antibodiesGENENTECH INC·Filed 2013·Granted Jun 17, 2014·8 cites·32 claims
- 1591US8734801B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted May 27, 2014·10 cites·32 claims
- 1690US8734797B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted May 27, 2014·10 cites·21 claims
- 1788US9067994B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted Jun 30, 2015·6 cites·19 claims
- 1886US11434287B2Anti-IL13 antibodies and uses thereofGENENTECH INC·Filed 2019·Granted Sep 6, 2022·2 cites·12 claims
- 1986US8329169B2Methods and compositions for the prevention and treatment of sepsisFUNG SEK CHUNG·Filed 2004·Granted Dec 11, 2012·46 cites·13 claims
- 2085US8513388B2Anti-Notch3 antibodiesLI KANG·Filed 2011·Granted Aug 20, 2013·7 cites·14 claims
- 2184US8956811B2Diagnosis of malignant neoplasms using anti-Notch3 antibodiesGENENTECH INC·Filed 2013·Granted Feb 17, 2015·6 cites·16 claims
- 2284US8148106B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesFUNG SEK CHUNG·Filed 2011·Granted Apr 3, 2012·5 cites·24 claims
- 2383US9873734B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesGENENTECH INC·Filed 2012·Granted Jan 23, 2018·4 cites·5 claims
- 2481US8329868B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesFUNG SEK CHUNG·Filed 2012·Granted Dec 11, 2012·3 cites·6 claims
- 2581US8187839B2Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseasesLI KANG·Filed 2011·Granted May 29, 2012·4 cites·15 claims
- 2677US9518124B2Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseasesGENENTECH INC·Filed 2013·Granted Dec 13, 2016·2 cites·20 claims
- 2768US5834599AImmunoconjugates which neutralize HIV-1 infectionTANOX BIOSYSTEMS INC·Filed 1993·Granted Nov 10, 1998·33 cites·4 claims
- 2867US2018251538A1Novel anti-il13 antibodies and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2967US2014303355A1Humanized Anti-Factor D Antibodies And Uses ThereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 3064US2017166630A1Humanized anti-factor d antibodies and uses thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 3161US2015376295A1Humanized Anti-Factor D Antibodies And Uses ThereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3261US2018291090A1Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseasesGENENTECH INC·Filed 2017·Application pending·0 cites
- 3361US2016002353A1Humanized Anti-Factor D Antibodies And Uses ThereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3461US2016002352A1Humanized Anti-Factor D Antibodies And Uses ThereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3558US2014335078A1Use Of Complement Inhibitors To Treat Ocular DiseasesGENENTECH INC·Filed 2014·Application pending·0 cites
- 3658US2009017031A1Methods for preventing and treating tissue damage associated with ischemia-reperfusion injuryGENENTECH INC·Filed 2008·Application pending·0 cites
- 3756US2012213785A1Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseasesLI KANG·Filed 2012·Application pending·0 cites
- 3855US2018334495A1Use of complement pathway inhibitors to treat ocular diseasesGENENTECH INC·Filed 2017·Application pending·0 cites
- 3954US2006121480A1Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndromeTANOX INC·Filed 2003·Application pending·0 cites
- 4052US2006140939A1Methods for preventing and treating tissue damage associated with ischemia-reperfusion injuryFUNG SEK C M·Filed 2004·Application pending·0 cites
- 4148US2013195881A1Potent, stable and non-immunosuppressive anti-cd4 antibodiesSINGH SANJAYA·Filed 2008·Application pending·0 cites
- 4245US2005169909A1Identification of novel IgE epitopesFiled 2004·Application pending·0 cites
- 4343US2009017016A1Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapyTANOX INC·Filed 2005·Application pending·0 cites
- 4442US2011200604A1IDENTIFICATION OF NOVEL IgE EPITOPESTANOX INC·Filed 2010·Application pending·0 cites
- 4540US2009053220A1Methods and compositions for the inhibition of hiv infection of t cellsDUENSING THOMAS·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →